NSE: ZYDUSWELL · 28 October 2026
- Zydus Wellness Ltd. (ZYDUSWELL) declined 1.44% today, settling at ₹465.20 compared to its previous close of ₹472.00. The stock traded within a day's range of ₹462.50 to ₹477.35, after opening with a positive gap of 1.13% at ₹477.35.
- In response to a media report regarding FSSAI notices over alleged misleading product claims, Zydus Wellness submitted formal clarifications to the stock exchanges. The company stated that it received the routine procedural notice from FSSAI on September 24, 2026, and submitted its detailed response on October 4, 2026. Management reiterated that all product label statements are factual and supported by scientific substantiation, asserting no material impact on operations.
- Trading volume was 0.46 times the 20-day average daily volume.
Why is Zydus Wellness share price falling on 28 October 2026?
Zydus Wellness Ltd. (ZYDUSWELL) declined 1.44% today, settling at ₹465.20 compared to its previous close of ₹472.00. The stock traded within a day's range of ₹462.50 to ₹477.35, after opening with a positive gap of 1.13% at ₹477.35.
The broader market and sector indices also experienced downward pressure, providing broader macro context for the session. The benchmark Nifty slipped 0.22%, while the Nifty FMCG sector benchmark fell 0.56%. Zydus Wellness underperformed both the headline index and its sector peers, extending its recent pullback following a 5.45% decline over the past 5 trading days and an 11.29% drop over the past 20 trading days.
On the corporate front, the recent exchange clarification regarding product labeling notices from FSSAI continued to circulate in market background, though the company had clarified that the statements on its product labels are factual and backed by scientific substantiation.
58,263 shares traded by 28 October 2026 · 03:25 PM IST. This compares with a 20-day average daily volume of 1.27 lakh shares (0.46 times). The five-day average daily volume was 1.02 lakh shares. Separately, the NSE report for 27 October 2026 showed 36,680 shares delivered, representing 40.39% of that day’s traded volume. The same report recorded 13,135 trades.
The stock's decline appears consistent with ongoing downside momentum following recent multi-session losses, with below-average volume indicating lack of aggressive institutional selling pressure or a single confirmed news catalyst for the day.
Latest Company Developments
In response to a media report regarding FSSAI notices over alleged misleading product claims, Zydus Wellness submitted formal clarifications to the stock exchanges. The company stated that it received the routine procedural notice from FSSAI on September 24, 2026, and submitted its detailed response on October 4, 2026. Management reiterated that all product label statements are factual and supported by scientific substantiation, asserting no material impact on operations.
Provides official clarity on regulatory inquiries, ensuring investors remain informed about product compliance without immediate financial fallout.
NSE Sustainability Ratings and Analytics Limited assigned Zydus Wellness an overall ESG rating of 72 for the financial year 2026, categorizing the company as a 'leader'. The unsolicited rating was independently prepared based on publicly available data and communicated to the company on October 15, 2026.
Highlights strong governance and sustainability standings recognized by institutional rating providers in the FMCG sector.
Mr. Arijit Sengupta tendered his resignation as Chief Marketing Officer due to personal circumstances requiring relocation to Mumbai, with his last working day effective September 18, 2026. The company formally notified the stock exchanges in compliance with regulatory disclosure requirements.
Senior management transitions require monitoring for continuity in marketing execution and brand strategy within the consumer wellness portfolio.
Significant increase in volume has been observed in Zydus Wellness Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Zydus Wellness Limited has submitted their response.
The exchange sought clarification from the company regarding a recent media report. Such a request is a verification step and does not by itself confirm the reported issue.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 18.72% on 30 September 2026. This compares with 18.73% on 30 June 2026, a change of -0.01 percentage points.
The filing reported 24 MF/UTI holders.
Research & Brokerage Views
Maintained a 'Buy' rating following quarterly financial reviews, acknowledging mixed operational numbers while projecting longer-term upside toward the target price.
What to Watch Next
- Upcoming unaudited financial results scheduled for board consideration on November 3, 2026
- Developments regarding regulatory interactions with FSSAI on product labeling substantiation
- Delivery volume trends and cash market participation relative to the 20-day average volume
- Management execution following recent senior leadership transitions
More Zydus Wellness news and dated analysis →
Frequently Asked Questions
What is the latest Zydus Wellness company news?
In response to a media report regarding FSSAI notices over alleged misleading product claims, Zydus Wellness submitted formal clarifications to the stock exchanges. The company stated that it received the routine procedural notice from FSSAI on September 24, 2026, and submitted its detailed response on October 4, 2026. Management reiterated that all product label statements are factual and supported by scientific substantiation, asserting no material impact on operations.
How strong was Zydus Wellness’s trading volume?
58,263 shares traded, 0.46 times the 20-day average daily volume. The price and volume data are dated 28 October 2026 · 03:25 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.